The global e-clinical solutions market, valued at $2,997.0 million in 2014, is predicted to grow with a CAGR of 13.7% during the forecast period (2015–2020). The growth of the market is attributed to the rapid clinical trial outsourcing, growing expenditure on clinical research and development by the pharmaceutical and biotechnology industry, increasing number of clinical trials, and rising need for improved data standardization.
Insights on market segments
In terms of delivery mode, web-based solutions held the largest share of the e-clinical solutions market in 2014. However, cloud-based solutions are predicted to witness the fastest growth, with a CAGR of 17.7%, during the forecast period.
Based on type, products held the larger share of the market (89.0%) in 2014. Among various classifications of products, clinical data management system (CDMS)/electronic data capture (EDC) solutions led the e-clinical solutions market during the historical period (2011–2014); however, electronic clinical outcome assessment (eCOA) is expected to experience the fastest growth during the forecast period, with a CAGR of 16.8%.
On the basis of end user, the pharmaceutical and biotechnology industry held the largest share of the e-clinical solutions market in 2014; however, clinical research organizations (CRO) are expected to experience the fastest growth, with a CAGR of 16.1% during the forecast period.
Asia-Pacific (APAC) to witness the fastest growth during the forecast period
The fastest growth in the e-clinical solutions market is expected to be witnessed by the APAC region during the forecast period. This is attributed to the increase in clinical trial outsourcing in developing countries. Due to cost-efficiency and availability of a large number of patients in countries including China and India, pharmaceutical industries are opting to conduct clinical trials in these countries.
Increasing need for data standardization driving the market
The most time-consuming part of drug development is clinical trials. E-clinical solutions help make the analysis faster by reducing the time spent on analyzing and gathering the data generated during these, thereby leading to a comparatively quicker introduction of drugs in the market. In order to enhance the pace of the drug development process, there is a rising need for data standardization, which is driving the growth of the e-clinical solutions market.
Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/e-clinical-solutions-market
Major market players increasingly engaging in mergers & acquisitions
The major e-clinical solutions market players are merging with or acquiring smaller companies to maintain their dominance. For instance, in May 2015, ERT acquired PHT Corporation to be able to offer enhanced solutions for patient data collection. Similarly, CCBR-SYNARC, a clinical services provider to pharmaceutical and biotechnology companies, signed a merger agreement with BioClinica in January 2014 to create a firm that can provide specialized outsourced clinical services around the world.
The key companies operating in the global e-clinical solutions market include Oracle Corporation, BioClinica, PAREXEL International Corporation, CRF Health Inc., Medidata Solutions, OmniComm Systems Inc., DATATRAK International Inc., and ERT.
GLOBAL E-CLINICAL SOLUTION MARKET SEGMENTATION
By Delivery Mode
By End User